HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,201 | +2.7% | 83,801 | -3.0% | 0.03% | +8.0% |
| Q2 2023 | $3,116 | -9.6% | 86,375 | -4.3% | 0.02% | -13.8% |
| Q1 2023 | $3,446 | -36.4% | 90,230 | -5.2% | 0.03% | -39.6% |
| Q4 2022 | $5,415 | -99.9% | 95,169 | -0.3% | 0.05% | +33.3% |
| Q3 2022 | $3,774,000 | -8.3% | 95,455 | +2.0% | 0.04% | -5.3% |
| Q2 2022 | $4,117,000 | +8.3% | 93,577 | -1.8% | 0.04% | +26.7% |
| Q1 2022 | $3,801,000 | -52.7% | 95,308 | -52.4% | 0.03% | 0.0% |
| Q4 2021 | $8,044,000 | +96.2% | 200,044 | +98.5% | 0.03% | -14.3% |
| Q3 2021 | $4,099,000 | -15.1% | 100,760 | -5.2% | 0.04% | -10.3% |
| Q2 2021 | $4,828,000 | +478.2% | 106,314 | +430.9% | 0.04% | +25.8% |
| Q1 2021 | $835,000 | -10.7% | 20,027 | -8.5% | 0.03% | -11.4% |
| Q4 2020 | $935,000 | +68.5% | 21,898 | +3.7% | 0.04% | +45.8% |
| Q3 2020 | $555,000 | -4.8% | 21,122 | -2.9% | 0.02% | -11.1% |
| Q2 2020 | $583,000 | +30.4% | 21,742 | -12.5% | 0.03% | +145.5% |
| Q1 2020 | $447,000 | -6.3% | 24,837 | -7.7% | 0.01% | +22.2% |
| Q4 2019 | $477,000 | +21.4% | 26,897 | +6.1% | 0.01% | +12.5% |
| Q3 2019 | $393,000 | -10.9% | 25,351 | -1.2% | 0.01% | -20.0% |
| Q2 2019 | $441,000 | +44.6% | 25,671 | +35.4% | 0.01% | +42.9% |
| Q1 2019 | $305,000 | +14.7% | 18,953 | +4.2% | 0.01% | -12.5% |
| Q4 2018 | $266,000 | -17.1% | 18,183 | -4.6% | 0.01% | 0.0% |
| Q2 2018 | $321,000 | +2.6% | 19,053 | +19.3% | 0.01% | 0.0% |
| Q1 2018 | $313,000 | -4.9% | 15,976 | -1.7% | 0.01% | -11.1% |
| Q4 2017 | $329,000 | +24.6% | 16,247 | +6.8% | 0.01% | +12.5% |
| Q3 2017 | $264,000 | +46.7% | 15,218 | +8.2% | 0.01% | +33.3% |
| Q2 2017 | $180,000 | +4.0% | 14,067 | +5.3% | 0.01% | -33.3% |
| Q1 2017 | $173,000 | +31.1% | 13,362 | -0.1% | 0.01% | +50.0% |
| Q4 2016 | $132,000 | -5.0% | 13,375 | +16.0% | 0.01% | -25.0% |
| Q3 2016 | $139,000 | +18.8% | 11,533 | +0.1% | 0.01% | +14.3% |
| Q2 2016 | $117,000 | +10.4% | 11,518 | +3.0% | 0.01% | -30.0% |
| Q1 2016 | $106,000 | -39.8% | 11,180 | +10.0% | 0.01% | -54.5% |
| Q4 2015 | $176,000 | +17.3% | 10,168 | -8.8% | 0.02% | +37.5% |
| Q3 2015 | $150,000 | -39.5% | 11,153 | +1.6% | 0.02% | -33.3% |
| Q2 2015 | $248,000 | +65.3% | 10,973 | +4.5% | 0.02% | +33.3% |
| Q1 2015 | $150,000 | +54.6% | 10,503 | +4.0% | 0.02% | +20.0% |
| Q4 2014 | $97,000 | +5.4% | 10,100 | +0.2% | 0.02% | +7.1% |
| Q3 2014 | $92,000 | -8.0% | 10,084 | -0.0% | 0.01% | -6.7% |
| Q2 2014 | $100,000 | – | 10,089 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |